Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Cash from Financing Activities (2016 - 2025)

Veracyte (VCYT) has disclosed Cash from Financing Activities for 14 consecutive years, with -$149000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 96.7% to -$149000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.2 million through Dec 2025, down 186.09% year-over-year, with the annual reading at -$4.2 million for FY2025, 186.09% down from the prior year.
  • Cash from Financing Activities hit -$149000.0 in Q4 2025 for Veracyte, down from $3.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $591.0 million in Q1 2021 to a low of -$6.5 million in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $30.2 million across 5 years, with a median of $285000.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: surged 269968.49% in 2021 and later plummeted 5045.45% in 2025.
  • Year by year, Cash from Financing Activities stood at $173000.0 in 2021, then plummeted by 46.24% to $93000.0 in 2022, then surged by 593.55% to $645000.0 in 2023, then plummeted by 799.22% to -$4.5 million in 2024, then surged by 96.7% to -$149000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for VCYT at -$149000.0 in Q4 2025, $3.0 million in Q3 2025, and -$566000.0 in Q2 2025.